Holen Sie sich die Stockscreener-App
20.22
0.90%
0.18
Handel nachbörslich:
20.22
Schlusskurs vom Vortag:
$20.04
Offen:
$19.7
24-Stunden-Volumen:
5.20M
Relative Volume:
0.74
Marktkapitalisierung:
$10.05B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
50.55
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
-1.12%
1M Leistung:
+9.12%
6M Leistung:
+132.95%
1J Leistung:
+40.71%
1-Tages-Spanne:
$19.61
$20.65
1-Wochen-Bereich:
$19.45
$20.65
52-Wochen-Spanne:
$8.02
$21.76
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
20.22 | 9.96B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
143.46 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.80 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.17 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.61 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Looking Into Elanco Animal Health Inc's Recent Short Interest - Sahm
Equitable Trust Co. Purchases 98,172 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Will breakout in Elanco Animal Health Incorporated lead to full recoveryTreasury Yields & AI Enhanced Market Trend Forecasts - newser.com
Elanco Animal Health Incorporated stock trend outlook and recovery path2025 Dividend Review & Entry Point Confirmation Signals - newser.com
Is Elanco Animal Health Incorporated stock poised for growthJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
Detecting support and resistance levels for Elanco Animal Health IncorporatedQuarterly Portfolio Summary & Target Return Focused Picks - newser.com
Elanco Animal Health (ELAN) Stock Analysis: Growth Potential And Market Dynamics - DirectorsTalk Interviews
Animal Healthcare Market Size, Trends Analysis 2032 by Key - openPR.com
Rep. Val T. Hoyle Sells Elanco Animal Health Incorporated (NYSE:ELAN) Shares - MarketBeat
Callan Family Office LLC Purchases 117,174 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Tick level data insight on Elanco Animal Health Incorporated volatilityLong Setup & Accurate Entry/Exit Alerts - newser.com
Elanco Animal Health Incorporated $ELAN Shares Sold by Truist Financial Corp - MarketBeat
Multi asset correlation models including Elanco Animal Health IncorporatedPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
Elanco Animal Health's (ELAN) Hold (C-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Pet Owner Keeps State, But Not Fed., Elanco Tick Meds Suit - Law360
Combining machine learning predictions for Elanco Animal Health IncorporatedJuly 2025 Decliners & Consistent Growth Equity Picks - newser.com
U.S. Animal Disinfectant Market 2025-2032: Industry Outlook, - openPR.com
Combining price and volume data for Elanco Animal Health IncorporatedJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com
What catalysts could drive Elanco Animal Health Incorporated stock higherWeekly Market Report & Weekly High Momentum Picks - newser.com
Elanco Escapes Some, but Not All, Claims in Animal Products Suit - Bloomberg Law News
Elanco Animal Health Hits New 52-Week High at $21.76 - Markets Mojo
Judge Limits Lawsuit Alleging Elanco Monopolized Pet Medication Market - PYMNTS.com
Hausfeld Expands Counsel Team with Former Government Enforcement Leaders - PYMNTS.com
Advantix-maker Elanco must face some price-fixing claims over flea, tick products - Reuters
Elanco Animal Health Incorporated (ELAN) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Acadia Healthcare names Todd Young as CFO amid activist investor pressure - Reuters
Elanco Animal Health (ELAN): Reviewing Valuation After Analyst Upgrade and S&P MidCap 400 Inclusion - Yahoo Finance
Country Club Bank Has $2.37 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (NYSE:ELAN) Sets New 12-Month High After Analyst Upgrade - MarketBeat
Elanco Animal Health upgraded to ’BB’ on lower leverage - Investing.com
Why Elanco (ELAN) Stock Is Trading Up Today - TradingView
Elanco Animal Health stock hits 52-week high at 21.18 USD - Investing.com Canada
Why Elanco Animal Health (ELAN) Is Up 5.4% After FDA Removes Major Zenrelia Safety Warning - Yahoo Finance
Elanco Animal Health (NYSE:ELAN) Rating Increased to Overweight at JPMorgan Chase & Co. - MarketBeat
JPMorgan Upgrades Elanco Animal Health to Overweight From Neutral, Adjusts Price Target to $24 From $18 - MarketScreener
This Netflix Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Benzinga
JP Morgan Upgrades Elanco Animal Health (ELAN) with Raised Price Target | ELAN Stock News - GuruFocus
Elanco Animal Health (NYSE:ELAN) Shares Gap Down to $20.56 - 富途牛牛
Elanco Animal Health (ELAN): Assessing Valuation After Recent Share Price Momentum - simplywall.st
Visual analytics tools that track Elanco Animal Health Incorporated performanceJuly 2025 Earnings & Safe Capital Growth Tips - newser.com
Can Elanco Animal Health Incorporated rally from current levelsQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
Using economic indicators to assess Elanco Animal Health Incorporated potentialJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Elanco Animal Health Hits New 52-Week High of $20.91 - Markets Mojo
Elanco Animal Health (ELAN) Is Up 8.2% After FDA Strengthens Zenrelia Safety Labeling – Has the Bull Case Changed? - simplywall.st
Q&A with Elanco’s Jeff Simmons on blockbusters, challenges and growing up on a vineyard - Indianapolis Business Journal
After 5 years, Elanco moves in to west side Indy headquarters. Take a look inside - IndyStar
Is this a good reentry point in Elanco Animal Health IncorporatedInsider Buying & AI Based Buy/Sell Signal Reports - newser.com
Can Elanco Animal Health Incorporated stock attract ESG investmentsTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Is Elanco Animal Health Incorporated stock a smart buy before Fed meetingTrade Risk Summary & Community Trade Idea Sharing - newser.com
How to build a dashboard for Elanco Animal Health Incorporated stockPortfolio Performance Report & High Accuracy Buy Signal Tips - newser.com
Sentiment analysis tools applied to Elanco Animal Health Incorporated2025 Retail Activity & Long-Term Growth Stock Strategies - newser.com
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
2.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):